The human amniotic fluid mesenchymal stem cells therapy on, SKOV3, ovarian cancer cell line
Abstract Purpose One of the most common malignancies peculiar to female health with few symptoms, low response to therapy, difficult diagnosis, frequent relapse, and high mortality, is ovarian cancer. Thus, our experiment, using Human amniotic fluid mesenchymal stem cells (hAFMSCs) as a therapeutic...
Main Authors: | Shiva Gholizadeh‐Ghaleh Aziz, Zahra Fardyazar, Maryam Pashaiasl |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-07-01
|
Series: | Molecular Genetics & Genomic Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/mgg3.726 |
Similar Items
-
Human amniotic fluid stem cells (hAFSCs) expressing p21 and cyclin D1 genes retain excellent viability after freezing with (dimethyl sulfoxide) DMSO
by: Shiva Gholizadeh-Ghaleh Aziz, et al.
Published: (2018-04-01) -
Methotrexate-induced apoptosis in human ovarian adenocarcinoma SKOV-3 cells via ROS-mediated bax/bcl-2-cyt-c release cascading
by: AlBasher G, et al.
Published: (2018-12-01) -
Unraveling the Catha edulis Extract Effects on the Cellular and Molecular Signaling in SKOV3 Cells
by: Alaa Sayed Abou-Elhamd, et al.
Published: (2021-05-01) -
Cytotoxicity of Standardized Curcuminoids Mixture against Epithelial Ovarian Cancer Cell Line SKOV-3
by: Heba Almosa, et al.
Published: (2020-03-01) -
Apoptotic and genomic effects of corilagin on SKOV3 ovarian cancer cell line
by: Attar R, et al.
Published: (2017-03-01)